LY-301317

LY-301317, also known as (R)-4,α-methylene-5-(1,3-oxazol-5-yl)-N,N-dipropyltryptamine ((R)-4,α-methylene-5-(1,3-oxazol-5-yl)-DPT), is a potent and selective serotonin 5-HT 1A receptor agonist which has been used in scientific research.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

LY-301317, also known as (R)-4,α-methylene-5-(1,3-oxazol-5-yl)-N,N-dipropyltryptamine ((R)-4,α-methylene-5-(1,3-oxazol-5-yl)-DPT), is a potent and selective serotonin 5-HT 1A receptor agonist which has been used in scientific research. It is a cyclized tryptamine and a partial ergoline.

The drug shows very high affinity for the serotonin 5-HT 1A receptor, with a K i of 0.26 nM, and is highly selective for this receptor over 9 other assessed targets. It produces various serotonin 5-HT 1A receptor agonist-associated effects in animals, including behavioral effects, hypothermia, antidepressant-like, anxiolytic-like, and antiemetic effects, and discriminative stimulus effects in drug discrimination tests.

LY-301317 was first described in the scientific literature in 1996.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1358480274 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.